Cargando…
Cell cycle phase perturbations by 6-diazo-5-oxo-L-norleucine and acivicin in normal and neoplastic human cell lines.
Autores principales: | Huber, K. R., Mayer, E. P., Mitchell, D. F., Roberts, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002038/ https://www.ncbi.nlm.nih.gov/pubmed/3620309 |
Ejemplares similares
-
Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
por: Cervantes-Madrid, Diana, et al.
Publicado: (2015) -
Discovery of tert-Butyl Ester Based
6-Diazo-5-oxo-l-norleucine Prodrugs
for Enhanced Metabolic Stability and Tumor Delivery
por: Novotná, Kateřina, et al.
Publicado: (2023) -
DDRE-04. THE COMBINED TREATMENT OF L-ASPARAGINASE AND 6-DIAZO-5-OXO-L-NORLEUCINE INHIBIT THE PROLIFERATION OF TEMOZOLOMIDE-SENSITIVE OR RESISTANT GLIOBLASTOMA CELLS
por: Ohba, Shigeo, et al.
Publicado: (2021) -
Decreased glutamate transport in acivicin resistant Leishmania tarentolae
por: Roy, Gaétan, et al.
Publicado: (2021) -
Target discovery of acivicin in cancer cells elucidates its mechanism of growth inhibition
por: Kreuzer, Johannes, et al.
Publicado: (2015)